Accueil>>Signaling Pathways>> Immunology/Inflammation>> PGE synthase>>HPGDS inhibitor 1

HPGDS inhibitor 1 (Synonyms: H-PGDS Inhibitor I)

Catalog No.GC14633

L'inhibiteur HPGDS 1 est un inhibiteur puissant, sélectif et actif par voie orale de la prostaglandine D hématopoÏétique (HPGDS) avec une CI50 de 0,6 nM et 32 nM dans les dosages enzymatiques et cellulaires, respectivement.

Products are for research use only. Not for human use. We do not sell to patients.

HPGDS inhibitor 1 Chemical Structure

Cas No.: 1033836-12-2

Taille Prix Stock Qté
5mg
177,00 $US
Ship Within 10-14 Days
10mg
250,00 $US
Ship Within 10-14 Days
25mg
396,00 $US
Ship Within 10-14 Days
50mg
658,00 $US
Please Inquire
100mg
950,00 $US
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

HPGDS inhibitor 1 is an oral potent and selective inhibitor of hematopoietic prostaglandin D synthase (HPGDS) with IC50 value of 0.7nM [1].

Prostaglandin D2 (PGD2) is a mediator of allergy and inflammation. It is isomerized from PGH2 by PGDS. This production is important in airway allergic and inflammatory processes. HPGDS inhibitor 1 has a 3-fluorine substituent, making it stable in the in vitro human microsome assay. It has potent effects in enzyme assay and cellular assay with IC50 values of 0.7nM and 32nM, respectively. In addition, the potency is equal against purified HPGDS from various species with IC50 values ranging from 0.5-2.3nM. Besides that, HPGDS inhibitor 1 is selective against HPGDS over other relevant human enzymes including L-PGDS, mPGES, COX-1, COX-2 and 5 LOX [1].

In a model of antigen-induced airway response in allergic sheep, treatment of HPGDS inhibitor 1 completely prevents the late asthma reaction and blocks the Airway hyper-responsiveness [1].

References:
[1] Carron C P, Trujillo J I, Olson K L, et al. Discovery of an oral potent selective inhibitor of hematopoietic prostaglandin D synthase (HPGDS). ACS Medicinal Chemistry Letters, 2010, 1(2): 59-63.

Avis

Review for HPGDS inhibitor 1

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for HPGDS inhibitor 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.